Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.320
-0.060 (-2.52%)
At close: Nov 13, 2026, 4:00 PM EST
2.250
-0.070 (-3.02%)
After-hours: Nov 13, 2026, 7:58 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $295.5 million as of November 13, 2026. It is the 18,033rd most valuable company in the world and the 3,181st biggest in the United States. Its market cap has increased by 35.24% in one year.
Market Cap
295.50M
Enterprise Value
235.67M
1-Year Change
35.24%
Global Rank
Country Rank
#3,181 United States
Category
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $295.50M, an increase of 152.49%. That is a compound annual growth rate of 17.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 295.50M | 19.98% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agenus | 326.68M |
| Ocugen | 325.87M |
| Scribe Therapeutics | 319.19M |
| Kyverna Therapeutics | 316.64M |
| Vicore Pharma Holding AB | 316.52M |
| Century Therapeutics | 315.07M |
| Turn Therapeutics | 314.86M |
| Evommune | 312.84M |